In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sterimedix Ltd.

Division of Bausch Health Companies Inc.
www.sterimedix.com

Latest From Sterimedix Ltd.

Deals Shaping The Medical Industry, October 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, Pharmaceuticals, and Research/Analytical Tools – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in September 2015.

BioPharmaceutical Medical Device

Medical Device Deals Update, February 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced January-February 2015.

Medical Device

Deals Shaping The Medical Industry, February 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, Pharmaceuticals, and Research/Analytical – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced December 2014-January 2015.

BioPharmaceutical Medical Device

Deals In Depth: December 2014

Pfizer received worldwide rights to Opko Health's Phase III human growth hormone Lagova; Merck and Otsuka made billion-dollar M&As in infectious and neurological diseases, respectively. Biopharma and device financing were down compared with November.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Consumables, Central Supplies
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Dermatology
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Bausch Health Companies Inc.
  • Senior Management
  • Ronnie McFarlane, Mng. Dir.
  • Contact Info
  • Sterimedix Ltd.
    Phone: 1527 501480
    Madeley Rd.
    Redditch
    Worcestershire, B98 9NB
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register